Sorrento receives Clinical Laboratory Improvement Amendments (CLIA) license from the State of California for clinical sample testing

Sorrento intends to initially offer three diagnostic tests for SARS-CoV-2 infection:

– RT-PCR Emergency Use Authorization (EUA)-approved test using nasal pharyngeal swab

– Laboratory developed test (COVI-STIX) using shallow nasal swab

– Laboratory